Joseph P Glenn from Alex City, AL

view source

Location:

Greater Philadelphia Area

Industry:

Chemicals

Pyrrolopyrimidine Derivatives As Tam Inhibitors
view source
US Patent:

20200181151, Jun 11, 2020
Filed:

Nov 15, 2019
Appl. No.:

16/684912
Inventors:

- Wilmington DE, US
David M. Burns - Plymouth Meeting PA, US
Hao Feng - Glen Mills PA, US
Joseph Glenn - Mount Royal NJ, US
Chunhong He - Boothwyn PA, US
Taisheng Huang - Wilmington DE, US
Song Mei - Wilmington DE, US
Jun Pan - Media PA, US
Xiaozhao Wang - Mt. Laurel NJ, US
Yingda Ye - Wilmington DE, US
International Classification:

C07D 487/04
C07D 471/04
C07D 519/00
Abstract:

This application relates to compounds of Formula I:or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.

Tricyclic Fused Thiophene Derivatives As Jak Inhibitors
view source
US Patent:

20140121198, May 1, 2014
Filed:

Oct 31, 2013
Appl. No.:

14/068796
Inventors:

- Wilmington DE, US
Wenyu Zhu - Media PA, US
Song Mei - Wilmington DE, US
Joseph Glenn - Mount Royal NJ, US
Assignee:

Incyte Corporation - Wilmington DE
International Classification:

C07D 495/14
US Classification:

51421021, 546 83, 514293, 544346, 514250, 544250, 514267, 435184
Abstract:

The present invention provides tricyclic fused thiophene derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.